DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Keflex (Cephalexin) - Adverse Event Reports - All Cases - Staphylococcal Skin Infection

 



Index of reports > All cases (26) > Cases with Staphylococcal Skin Infection (2)

Below is the selection of adverse event reports related to Keflex (Cephalexin) that includes all cases where reactions include staphylococcal skin infection.

Adverse event in 81 year old female receiving Keflex (Cephalexin)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-21

Patient: 81 year old female

Adverse reactions / side effects: Staphylococcal Skin Infection, Nasopharyngitis, Furuncle, Drug Hypersensitivity

Suspect drug(s):
Revlimid
    Dosage: 10 mg, 1 in 1 d; oral, 20 mg, x28 days; oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2007-01-01

Revlimid
    Dosage: 10 mg, 1 in 1 d; oral, 20 mg, x28 days; oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2007-02-01

Keflex
    Indication: Furuncle
    Start date: 2007-05-01
    End date: 2007-05-12

Other drugs received by patient: Blood Pressure Pill (Antihypertensives) (Pill)



Adverse event in 58 year old female receiving Keflex (Cephalexin)

Reported by a physician from United States on 2007-01-30

Patient: 58 year old female

Adverse reactions / side effects: Staphylococcal Skin Infection, Toxic Epidermal Necrolysis, Oral Mucosal Exfoliation, Eosinophilia, Fatigue, Malaise, Erythema Multiforme, Application Site Scab

Suspect drug(s):
Aldara
    Dosage: (0.5 sachet, 5 in 1 week (s)), topical
    Administration route: Topical
    Indication: Actinic Keratosis
    Start date: 2006-01-01
    End date: 2006-01-01

Aldara
    Dosage: (0.5 sachet, 5 in 1 week (s)), topical
    Administration route: Topical
    Indication: Basal Cell Carcinoma
    Start date: 2006-01-01
    End date: 2006-01-01

Aldara
    Dosage: (0.5 sachet, 5 in 1 week (s)), topical
    Administration route: Topical
    Indication: Actinic Keratosis
    Start date: 2006-12-25
    End date: 2007-01-13

Aldara
    Dosage: (0.5 sachet, 5 in 1 week (s)), topical
    Administration route: Topical
    Indication: Basal Cell Carcinoma
    Start date: 2006-12-25
    End date: 2007-01-13

Altace

Hydrochlorothiazide

Zetia

Folic Acid

Aspirin

Fish OIL

Keflex

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009